Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Capital Expenditures (2016 - 2025)

Celcuity's (CELC) quarterly Capital Expenditures came in at $53000.0 in Q4 2025, up 17.78% YoY from $45000.0 in Q4 2024, and down 45.36% on a QoQ basis from $97000.0 in Q3 2025.

Analysis

Celcuity (CELC) Capital Expenditures (2016 - 2025) Analysis & Trends

Celcuity (CELC) has 10 years of Capital Expenditures data on file, last reported at $53000.0 in Q4 2025.

  • Quarterly Capital Expenditures rose 17.78% year-over-year to $53000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $249000.0 (changed 0.4% YoY) and the FY2025 annual result came in at $249000.0, changed 0.4% from the prior year.
  • Capital Expenditures retreated to $53000.0 in Q4 2025, from $97000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $112044.0 in Q4 2022 to a low of $4854.0 in Q2 2023.
  • A 5-year average of $41865.5 and a median of $35849.5 in 2023 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2023 — Capital Expenditures tumbled 78.88% — and 2024, when it soared 1218.5%.
  • Tracing CELC's Capital Expenditures over 5 years: stood at $9939.0 in 2021, then soared by 1027.32% to $112044.0 in 2022, then tumbled by 70.82% to $32699.0 in 2023, then surged by 37.62% to $45000.0 in 2024, then rose by 17.78% to $53000.0 in 2025.
  • The last three Capital Expenditures figures came in at $53000.0 (Q4 2025), $97000.0 (Q3 2025), and $39000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Celcuity 5.25 Bn 5.25 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 53,000.00
Sep 30, 2025 97,000.00
Jun 30, 2025 39,000.00
Mar 31, 2025 60,000.00
Dec 31, 2024 45,000.00
Sep 30, 2024 51,000.00
Jun 30, 2024 64,000.00
Mar 31, 2024 90,000.00
Dec 31, 2023 32,699.00
Sep 30, 2023 53,104.00
Jun 30, 2023 4,854.00
Mar 31, 2023 6,987.00
Dec 31, 2022 112,044.00
Sep 30, 2022 12,103.00
Jun 30, 2022 22,986.00
Mar 31, 2022 11,635.00
Dec 31, 2021 9,939.00
Sep 30, 2021 14,062.00
Jun 30, 2021 26,972.00
Mar 31, 2021 30,925.00